Copyright Reports & Markets. All rights reserved.

Global Nocturia Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Nocturia by Type
    • 1.3.1 Overview: Global Nocturia Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Nocturia Consumption Value Market Share by Type in 2023
    • 1.3.3 Desmopressin
    • 1.3.4 Anticholinergic Drugs
    • 1.3.5 Alpha Blockers
    • 1.3.6 Diuretics
    • 1.3.7 Others
  • 1.4 Global Nocturia Market by Sale Channels
    • 1.4.1 Overview: Global Nocturia Market Size by Sale Channels: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Pharmacies
  • 1.5 Global Nocturia Market Size & Forecast
  • 1.6 Global Nocturia Market Size and Forecast by Region
    • 1.6.1 Global Nocturia Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Nocturia Market Size by Region, (2019-2030)
    • 1.6.3 North America Nocturia Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Nocturia Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Nocturia Market Size and Prospect (2019-2030)
    • 1.6.6 South America Nocturia Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Nocturia Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Astellas Pharma
    • 2.1.1 Astellas Pharma Details
    • 2.1.2 Astellas Pharma Major Business
    • 2.1.3 Astellas Pharma Nocturia Product and Solutions
    • 2.1.4 Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Astellas Pharma Recent Developments and Future Plans
  • 2.2 Allergan
    • 2.2.1 Allergan Details
    • 2.2.2 Allergan Major Business
    • 2.2.3 Allergan Nocturia Product and Solutions
    • 2.2.4 Allergan Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Allergan Recent Developments and Future Plans
  • 2.3 Ferring Pharmaceuticals
    • 2.3.1 Ferring Pharmaceuticals Details
    • 2.3.2 Ferring Pharmaceuticals Major Business
    • 2.3.3 Ferring Pharmaceuticals Nocturia Product and Solutions
    • 2.3.4 Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Ferring Pharmaceuticals Recent Developments and Future Plans
  • 2.4 Eli Lilly
    • 2.4.1 Eli Lilly Details
    • 2.4.2 Eli Lilly Major Business
    • 2.4.3 Eli Lilly Nocturia Product and Solutions
    • 2.4.4 Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Eli Lilly Recent Developments and Future Plans
  • 2.5 GlaxoSmithKline
    • 2.5.1 GlaxoSmithKline Details
    • 2.5.2 GlaxoSmithKline Major Business
    • 2.5.3 GlaxoSmithKline Nocturia Product and Solutions
    • 2.5.4 GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.6 Sanofi
    • 2.6.1 Sanofi Details
    • 2.6.2 Sanofi Major Business
    • 2.6.3 Sanofi Nocturia Product and Solutions
    • 2.6.4 Sanofi Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sanofi Recent Developments and Future Plans
  • 2.7 Pfizer
    • 2.7.1 Pfizer Details
    • 2.7.2 Pfizer Major Business
    • 2.7.3 Pfizer Nocturia Product and Solutions
    • 2.7.4 Pfizer Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Pfizer Recent Developments and Future Plans
  • 2.8 Abbott
    • 2.8.1 Abbott Details
    • 2.8.2 Abbott Major Business
    • 2.8.3 Abbott Nocturia Product and Solutions
    • 2.8.4 Abbott Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Abbott Recent Developments and Future Plans
  • 2.9 Teva
    • 2.9.1 Teva Details
    • 2.9.2 Teva Major Business
    • 2.9.3 Teva Nocturia Product and Solutions
    • 2.9.4 Teva Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Teva Recent Developments and Future Plans
  • 2.10 Mylan
    • 2.10.1 Mylan Details
    • 2.10.2 Mylan Major Business
    • 2.10.3 Mylan Nocturia Product and Solutions
    • 2.10.4 Mylan Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Mylan Recent Developments and Future Plans
  • 2.11 Johnson & Johnson
    • 2.11.1 Johnson & Johnson Details
    • 2.11.2 Johnson & Johnson Major Business
    • 2.11.3 Johnson & Johnson Nocturia Product and Solutions
    • 2.11.4 Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.12 Hainan Zhonghe Pharmaceutical
    • 2.12.1 Hainan Zhonghe Pharmaceutical Details
    • 2.12.2 Hainan Zhonghe Pharmaceutical Major Business
    • 2.12.3 Hainan Zhonghe Pharmaceutical Nocturia Product and Solutions
    • 2.12.4 Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Hainan Zhonghe Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Nocturia Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Nocturia by Company Revenue
    • 3.2.2 Top 3 Nocturia Players Market Share in 2023
    • 3.2.3 Top 6 Nocturia Players Market Share in 2023
  • 3.3 Nocturia Market: Overall Company Footprint Analysis
    • 3.3.1 Nocturia Market: Region Footprint
    • 3.3.2 Nocturia Market: Company Product Type Footprint
    • 3.3.3 Nocturia Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Nocturia Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Nocturia Market Forecast by Type (2025-2030)

5 Market Size Segment by Sale Channels

  • 5.1 Global Nocturia Consumption Value Market Share by Sale Channels (2019-2024)
  • 5.2 Global Nocturia Market Forecast by Sale Channels (2025-2030)

6 North America

  • 6.1 North America Nocturia Consumption Value by Type (2019-2030)
  • 6.2 North America Nocturia Market Size by Sale Channels (2019-2030)
  • 6.3 North America Nocturia Market Size by Country
    • 6.3.1 North America Nocturia Consumption Value by Country (2019-2030)
    • 6.3.2 United States Nocturia Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Nocturia Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Nocturia Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Nocturia Consumption Value by Type (2019-2030)
  • 7.2 Europe Nocturia Consumption Value by Sale Channels (2019-2030)
  • 7.3 Europe Nocturia Market Size by Country
    • 7.3.1 Europe Nocturia Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Nocturia Market Size and Forecast (2019-2030)
    • 7.3.3 France Nocturia Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Nocturia Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Nocturia Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Nocturia Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Nocturia Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Nocturia Consumption Value by Sale Channels (2019-2030)
  • 8.3 Asia-Pacific Nocturia Market Size by Region
    • 8.3.1 Asia-Pacific Nocturia Consumption Value by Region (2019-2030)
    • 8.3.2 China Nocturia Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Nocturia Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Nocturia Market Size and Forecast (2019-2030)
    • 8.3.5 India Nocturia Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Nocturia Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Nocturia Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Nocturia Consumption Value by Type (2019-2030)
  • 9.2 South America Nocturia Consumption Value by Sale Channels (2019-2030)
  • 9.3 South America Nocturia Market Size by Country
    • 9.3.1 South America Nocturia Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Nocturia Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Nocturia Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Nocturia Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Nocturia Consumption Value by Sale Channels (2019-2030)
  • 10.3 Middle East & Africa Nocturia Market Size by Country
    • 10.3.1 Middle East & Africa Nocturia Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Nocturia Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Nocturia Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Nocturia Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Nocturia Market Drivers
  • 11.2 Nocturia Market Restraints
  • 11.3 Nocturia Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Nocturia Industry Chain
  • 12.2 Nocturia Upstream Analysis
  • 12.3 Nocturia Midstream Analysis
  • 12.4 Nocturia Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
    According to our (Global Info Research) latest study, the global Nocturia market size was valued at US$ 2351 million in 2023 and is forecast to a readjusted size of USD 3709 million by 2030 with a CAGR of 6.8% during review period.
    Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
    This report is a detailed and comprehensive analysis for global Nocturia market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Sale Channels. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Nocturia market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Nocturia market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Nocturia market size and forecasts, by Type and by Sale Channels, in consumption value ($ Million), 2019-2030
    Global Nocturia market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nocturia
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nocturia market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Nocturia market is split by Type and by Sale Channels. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Sale Channels. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Nocturia market is split by Type and by Sale Channels. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Sale Channels. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Desmopressin
    Anticholinergic Drugs
    Alpha Blockers
    Diuretics
    Others
    Market segment by Sale Channels
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Market segment by players, this report covers
    Astellas Pharma
    Allergan
    Ferring Pharmaceuticals
    Eli Lilly
    GlaxoSmithKline
    Sanofi
    Pfizer
    Abbott
    Teva
    Mylan
    Johnson & Johnson
    Hainan Zhonghe Pharmaceutical
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Nocturia product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Nocturia, with revenue, gross margin, and global market share of Nocturia from 2019 to 2024.
    Chapter 3, the Nocturia competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Sale Channels, with consumption value and growth rate by Type, by Sale Channels, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nocturia market forecast, by regions, by Type and by Sale Channels, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Nocturia.
    Chapter 13, to describe Nocturia research findings and conclusion.

    Buy now